Last Updated : October 9, 2018
Details
FilesGeneric Name:
Adalimumab
Project Status:
Complete
Therapeutic Area:
Ulcerative colitis
Manufacturer:
AbbVie Corporation
Call for patient/clinician input open:
Brand Name:
Humira
Project Line:
Reimbursement Review
Project Number:
SR0450-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC
Submission Type:
Initial
Indications:
Ulcerative Colitis
Recommendation Type:
Do not list at the submitted price
Final Recommendation:
Files
Last Updated : October 9, 2018